Claritin Articles
S-P's Claritin Syrup Approved In USA
28 October 1996
Major US Drug Cos Post Strong Results In 3rd Qtr
28 October 1996
US NAPM Slams "Pediatric Research" Patent Extensions Plans
14 October 1996
Hoechst Aims For Two NCEs Each Year
23 September 1996
Fexofenadine Launched In Its First Market
2 September 1996
Single-Digit Profits Growth For B-MS And W-L
5 August 1996
Hoechst Gain US Allergy Drug Approval
5 August 1996
New York Stock Comment
8 July 1996
Schering-Plough Forecasts 15% EPS Rise For 1996
10 June 1996
US Firms' Strong 1st Qtr Lifts Share Prices
29 April 1996
Tylenol/Advil Ad Row "A US Investment Non-Event"
1 April 1996
Losec "Will Be The World's Top-Selling Drug In 2000"
26 February 1996
Transition For AHP in 1995; Year-End Results
5 February 1996
US Drug Cos Reveal Strong Growth In 1995 3rd Qtr
30 October 1995
Schering-Plough's Claritin: USA approval
9 October 1995
Strong International Sales For US Cos In 2nd Qtr
31 July 1995
US Sales of Generic Drugs Up 29% In 1994, Says IMS
17 July 1995
Solid 2nd Qtr Earnings Growth For US Drugmakers
17 July 1995
Schering-Plough Is "Right-Sized And Flexible"
3 July 1995
January Rx Trends In The USA
13 March 1995
End Of Year Encouraging For US Companies
6 February 1995
S-P's Claritin-D Approved In USA
21 November 1994
Strong Gains By US Firms In 2nd Quarter
1 August 1994
ANTIHISTAMINE SAFETY QUESTIONED?
30 May 1994
SMITHKLINE BEECHAM GIVING TAGAMET REBATES
15 November 1993
CURRENCY EXCHANGE FACTOR HITS US 3rd QTR
8 November 1993
MARKET WARMS TO COUGH & COLD SEASON IN USA
1 November 1993
CHANGES TO UK DRUG STATUS
16 August 1993
NICOTINE PATCH COs SUFFER DECLINE IN US SALES
2 August 1993
DELISTING AND OTC SALES IN DENMARK
26 July 1993
NEW YORK STOCK COMMENT
21 June 1993
US DRUGMAKERS AND "THE BLACK HOLE"
21 June 1993
EARNINGS GROWTH EXPANSION SEEN FOR UCB
31 May 1993
MURPHY'S LAW PERVADES US DRUG STOCKS
17 May 1993
STRONG GROWTH BY US PHARMA COs IN 1st QTR
10 May 1993
SCHERING-PLOUGH NOW "MORE EFFICIENT"
10 May 1993
CLARITIN LAUNCH IN USA
26 April 1993
PFIZER CONSIDERS PRICE CUTS
29 March 1993
S-P HOPES FOR IMMINENT APPROVAL
22 February 1993
NEW YORK STOCK COMMENT
22 February 1993
SCHERING-PLOUGH'S CLARITYN GOES OTC
1 February 1993
ACICLOVIR SHOULD GO OTC, SAYS UK MCA
1 February 1993
SCHERING-PLOUGH KEEPS RECOMMENDATION
25 January 1993
GOOD GROWTH FOR US COMPANIESCONTINUES FOR US COs
3 August 1992
CANADA TOUGHENS ANTIHISTAMINES STANCE
3 August 1992
NORTH AMERICA'S OTC COUGH COLD MARKET
9 March 1992
US OTC DRUGMAKERS A TAKEOVER TARGET
17 February 1992
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
